Home > Financial Ratios > MARKSANS PHARMA

MARKSANS PHARMA
Working Capital/Sales

    Back to All Ratios
MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for MARKSANS PHARMA
Please provide your vote to see the results

MARKSANS PHARMA Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Working Capital/Sales(x) 1.551.531.832.303.11

What is the latest Working Capital/Sales ratio of MARKSANS PHARMA ?

The latest Working Capital/Sales ratio of MARKSANS PHARMA is 1.55 based on Mar2024 Consolidated results.
Year Working Capital/Sales
Mar20241.55
Mar20231.53
Mar20221.83
Mar20212.30
Mar20203.11

How is Working Capital/Sales of MARKSANS PHARMA Trending?

Years Working Capital/Sales % Change
Mar2024 1.55
1.31
Mar2023 1.53
-16.39
Mar2022 1.83
-20.43
Mar2021 2.3
-26.05
Mar2020 3.11 -

Other Financial Ratios of MARKSANS PHARMA


Compare Working Capital/Sales ratio of peers of MARKSANS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MARKSANS PHARMA ₹12,932.1 Cr -3.8% -18% 80% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹443,145.0 Cr -2% 2.1% 42.6% Stock Analytics
DIVIS LABORATORIES ₹156,280.0 Cr -3.5% -3.4% 49.9% Stock Analytics
CIPLA ₹120,379.0 Cr -2.6% -0.6% 17.9% Stock Analytics
DR REDDYS LABORATORIES ₹112,701.0 Cr -2.7% 8.9% 14.2% Stock Analytics
ZYDUS LIFESCIENCES ₹96,774.5 Cr -1% -1.7% 36.9% Stock Analytics


MARKSANS PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MARKSANS PHARMA

-3.8%

-18%

80%

SENSEX

-0.4%

-3.7%

7.9%


You may also like the below Video Courses